| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |